ac2c04196_si_001.xlsx (58.58 kB)
Miniaturized Two-Dimensional Heart Cutting for LC–MS-Based Metabolomics
datasetposted on 2023-01-30, 12:39 authored by Carla Orlandi, Carine Jacques, Hélène Duplan, Laurent Debrauwer, Emilien L. Jamin
Liquid chromatography–mass spectrometry (LC–MS)-based metabolomics usually combines hydrophilic interaction liquid chromatography (HILIC) and reversed-phase (RP) chromatography to cover a wide range of metabolomes, requiring both significant sample consumption and analysis time for separate workflows. We developed an integrated workflow enabling the coverage of both polar and nonpolar metabolites with only one injection of the sample for each ionization mode using heart-cutting trapping to combine HILIC and RP separations. This approach enables the trapping of some compounds eluted from the first chromatographic dimension for separation later in the second dimension. In our case, we applied heart-cutting to non-retained metabolites in the first dimension. For that purpose, two independent miniaturized one-dimensional HILIC and RP methods were developed by optimizing the chromatographic and ionization conditions using columns with an inner diameter of 1 mm. They were then merged into one two-dimensional micro LC–MS method by optimization of the trapping conditions. Equilibration of the HILIC column during elution on the RP column and vice versa reduced the overall analysis time, and the multidimensionality allows us to avoid signal measurements during the solvent front. To demonstrate the benefits of this approach to metabolomics, it was applied to the analysis of the human plasma standard reference material SRM 1950, enabling the detection of hundreds of metabolites without the significant loss of some of them while requiring an injection volume of only 0.5 μL.
vice versa reducedmultidimensionality allows uslc – msavoid signal measurementsintegrated workflow enablingsignificant sample consumptionoverall analysis timedimensional heart cuttingfirst chromatographic dimensionfirst dimensionsignificant lossanalysis timesecond dimensiondimensional hilicwide rangesolvent frontseparation laterseparate workflowsretained metabolitesone twoone injectionnonpolar metabolitesminiaturized twometabolites withoutinner diameterinjection volumecompounds elutedapplied heart5 μl1 mm